Semaglutide cash prices settle between $149 and $499 a month as list prices stay above $1,000
Cash prices for branded semaglutide have settled between $149 and $499 a month, but the lowest rates depend on dose and on a limited-time introductory offer.
Branded semaglutide prices paid in cash have settled into a range of $149 to $499 a month as of mid-September 2026, while the list prices for the same medicines remain above $1,000, according to Novo Nordisk's NovoCare pharmacy [1] and the federal TrumpRx price site [2].
The cheapest route is the pill. NovoCare lists the Wegovy pill starting at $149 a month and the Ozempic pill starting at $149 a month [1]. Wegovy pill pricing varies by dose: $149 a month for 1.5 mg, $199 for 4 mg, and $299 for 9 mg and 25 mg [3]. NovoCare says Ozempic pill self-pay pricing also varies by dose, without listing every dose on its main pharmacy page [1].
The pens follow a similar pattern. Patients new to the Wegovy or Ozempic savings offers and NovoCare Pharmacy pay $199 a month for the 0.25 mg and 0.5 mg doses, for two monthly fills through December 31, 2026. After that, the standard self-pay price is $349 a month for Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg, and for Ozempic 0.25 mg, 0.5 mg and 1 mg. Ozempic 2 mg is $499 a month [1]. Wegovy HD, the 7.2 mg injection, is listed at $399 a month [1][3].
Against those figures, TrumpRx shows original prices of $1,349 a month for Wegovy and $1,028 for Ozempic [2]. The same site lists the Wegovy pill at $149 a month and the Wegovy and Ozempic pens at $199 a month [2]. It also lists Zepbound, a tirzepatide product, at $299 a month against an original price of $1,087 [2].
For people using commercial insurance, NovoCare says the copay can be as little as $25 a month for up to three months, subject to a maximum savings of $100 a month, and that government beneficiaries are excluded from that offer [1][3]. All doses of Wegovy and Ozempic require a prescription [1]. NovoCare also states that compounded semaglutide is not FDA-approved [1].
Novo Nordisk says it reserves the right to modify or cancel these programs at any time, with full terms held on separate savings-card and pharmacy pages [1][3].
Why it matters for patients
The distance between list price and cash price is now wide enough that the amount a person pays depends mostly on which version and dose is prescribed and how they pay. For someone paying cash, the difference between the cheapest pill at $149 a month and Ozempic 2 mg at $499 a month is $350 [1].
The pen price is also time-limited. The $199 rate applies to two monthly fills for patients new to the offer, then rises to $349, or $499 for Ozempic 2 mg [1]. The $25 insurance copay is capped at $100 a month in savings and excludes government beneficiaries, so people covered by Medicare or Medicaid are not eligible for that particular offer [1][3].
Novo Nordisk has not disclosed how long the $149 pill price will last. It has not been reported whether other pharmacies will match these cash prices, or whether list prices will change.
What happens next
The introductory $199 pen price is scheduled to run for two monthly fills through December 31, 2026, after which the standard rate applies: $349 a month for Wegovy and for Ozempic up to 1 mg, or $499 a month for Ozempic 2 mg [1][3]. No end date for the $149 pill price has been reported, and Novo Nordisk says it can change or cancel the programs at any time [1][3].
Sources
Semaglutides.org provides information only, not medical advice. Talk to a licensed provider about your own care before making changes. Some telehealth links are affiliate links and are labeled where they appear.